Skip to main content

Table 1 Baseline participant characteristics in total participants and subgroups stratified by baseline systolic blood pressure level

From: Lack of a bridge between screening and medical management for hypertension: health screening cohort in Japan

Variables Total Baseline systolic blood pressure
N = 153,523 < 140 mmHg n = 132,653 140–159 mmHg n = 16,720 ≥160 mmHg n = 4150
Age, years 49.8 (8.3) 49.2 (8.1) 53.0 (8.8) 54.5 (8.6)
BMI, kg/m2 23.3 (3.6) 23.0 (3.5) 24.9 (3.9) 25.3 (4.3)
HbA1c, % 5.6 (0.6) 5.5 (0.6) 5.7 (0.8) 5.8 (1.1)
Systolic blood pressure, mmHg 122.6 (16.7) 118.0 (12.0) 147.1 (5.5) 171.3 (11.6)
Diastolic blood pressure, mmHg 75.9 (12.0) 73.3 (9.9) 90.4 (8.9) 101.2 (11.9)
LDL cholesterol, mg/dL 127.2 (32.2) 126.6 (31.9) 131.0 (33.9) 132.6 (35.4)
   n (%) n (%) n (%)
Men 99,474 (64.8) 83,287 (62.8) 12,972 (77.6) 3215 (77.5)
Current smoking 45,280 (29.5) 37,955 (28.6) 5744 (34.4) 1581 (38.1)
Drinking alcohol: Not everyday 89,877 (67.4) 79,862 (69.0) 8094 (57.5) 1921 (54.9)
Drinking alcohol: Everyday, small amount 30,537 (22.9) 25,752 (22.3) 3822 (27.1) 963 (27.5)
Drinking alcohol: Everyday, large amount 12,895 (9.7) 10,113 (8.7) 2167 (15.4) 615 (17.6)
Diagnosed comorbidities
 Diabetes 3015 (2.0) 2474 (1.9) 445 (2.7) 96 (2.3)
 Cancer 2845 (1.9) 2493 (1.9) 295 (1.8) 57 (1.4)
 Chronic lung disease 7879 (5.1) 7059 (5.3) 701 (4.2) 119 (2.9)
 Liver disease 6092 (4.0) 5238 (4.0) 716 (4.3) 138 (3.3)
 Peptic ulcer 6119 (4.0) 5356 (4.0) 654 (3.9) 109 (2.6)
 Cerebrovascular disease 1677 (1.1) 1476 (1.1) 172 (1.0) 29 (0.7)
 Peripheral vascular disease 1737 (1.1) 1521 (1.2) 181 (1.1) 35 (0.8)
 Insomnia 5492 (3.6) 4974 (3.8) 455 (2.7) 63 (1.5)
 Depression 3093 (2.0) 2851 (2.2) 217 (1.3) 25 (0.6)
  1. Abbreviations: M mean, SD standard deviation, BMI body mass index